We are live on ! Find out more
ANIK icon

Anika Therapeutics
ANIK

160 hedge funds and large institutions have $483M invested in Anika Therapeutics in 2014 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 56 increasing their positions, 57 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 15

19% more capital invested

Capital invested by funds: $405M → $483M (+$77.5M)

5% more funds holding

Funds holding: 153 → 160 (+7)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2% less repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 57

45% less call options, than puts

Call options by funds: $1.89M | Put options by funds: $3.46M

Holders
160
Holders Change
+7
Holders Change %
+4.58%
% of All Funds
4.27%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
25
Increased
56
Reduced
57
Closed
15
Calls
$1.89M
Puts
$3.46M
Net Calls
-$1.56M
Net Calls Change
-$368K

Top Buyers

1
RIM
Ranger Investment Management
Texas
+$15.4M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$12.6M
3
BTW
Boston Trust Walden
Massachusetts
+$12.3M
4
LCP
Lombardia Capital Partners
California
+$5.5M
5
BFA
BlackRock Fund Advisors
California
+$2.93M

Top Sellers

1
Millennium Management
Millennium Management
New York
-$8.04M
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$5.7M
3
Morgan Stanley
Morgan Stanley
New York
-$4.66M
4
NI
Numeric Investors
Massachusetts
-$3.26M
5
TC
TFS Capital
Pennsylvania
-$2.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
AG
126
Algert Global
California
$207K +$199K +5,080 New
LG
127
Laidlaw Group
New York
$205K +$197K +5,040 New
AL
128
Airain Ltd
Guernsey
$203K -$791K -20,230 -80%
BJ
129
BlackRock Japan
Japan
$196K -$16.1K -413 -8%
SG Americas Securities
130
SG Americas Securities
New York
$165K +$158K +4,044 New
QT
131
Quantbot Technologies
New York
$157K -$229K -5,865 -60%
PI
132
PineBridge Investments
New York
$133K +$5.43K +139 +4%
Bank of Montreal
133
Bank of Montreal
Ontario, Canada
$131K +$3.56K +91 +3%
IPC
134
Independent Portfolio Consultants
Florida
$100K -$350K -8,945 -78%
Legal & General Group
135
Legal & General Group
United Kingdom
$89K – – –
Citigroup
136
Citigroup
New York
$87K -$129K -3,311 -61%
JFGIW
137
Johnson Financial Group Inc (Wisconsin)
Wisconsin
$80K +$29.3K +750 +61%
MSA
138
Mason Street Advisors
Wisconsin
$76K +$2.27K +58 +3%
Canada Life
139
Canada Life
Manitoba, Canada
$73K – – –
EARNEST Partners
140
EARNEST Partners
Georgia
$61K – – –
US Bancorp
141
US Bancorp
Minnesota
$60K – – –
MCM
142
Manchester Capital Management
Vermont
$60K +$27.4K +700 +90%
Group One Trading
143
Group One Trading
Illinois
$57K +$15.4K +395 +39%
OA
144
OFI Advisors
Pennsylvania
$54K +$9.15K +234 +21%
Creative Planning
145
Creative Planning
Kansas
$41K -$860 -22 -2%
Simplex Trading
146
Simplex Trading
Illinois
$34K +$32.2K +825 New
Barclays
147
Barclays
United Kingdom
$33K -$30.8K -789 -49%
LTFS
148
Ladenburg Thalmann Financial Services
Florida
$32K -$133K -3,400 -81%
MSFP
149
Mark Sheptoff Financial Planning
Connecticut
$20K -$23.5K -600 -55%
Norges Bank
150
Norges Bank
Norway
$20K +$19.5K +500 New
3 4 5
6
7

ANIK Hedge Fund Activity: Q4 2014 in Review

160 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Anika Therapeutics (ANIK) for Q4 2014, worth a combined $483M — up 19% from $405M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new ANIK positions and 15 closed out — a net gain of 10 holders — while 56 added to existing stakes and 57 trimmed.

The largest buyer was Ranger Investment Management, adding an estimated $15.4M. The largest seller was Millennium Management, cutting an estimated $8.04M.

  • 160 institutional investors held Anika Therapeutics (ANIK) as of Q4 2014, up from 153 in Q3 2014.
  • Funds reported $483M of Anika Therapeutics stock for Q4 2014, up 19% quarter-over-quarter.
  • 25 funds opened new Anika Therapeutics positions in Q4 2014 and 15 closed out, a net change of +10 holders.
  • The largest Anika Therapeutics buyer in Q4 2014 was Ranger Investment Management, an estimated $15.4M added.
  • The largest Anika Therapeutics seller in Q4 2014 was Millennium Management, an estimated $8.04M sold.

Based on aggregated 13F filings for Q4 2014.